Orange County, CA (PRWEB) September 16, 2013 The premier stem cell clinic in California, TeleHealth, is now offering bone marrow derived stem cell injections for numerous musculoskeletal conditions. The stem cell therapy is typically covered by insurance and is an excellent treatment for conditions such as degenerative arthritis, rotator cuff tendonitis, achilles tendonitis, tennis elbow and much more. For more information and scheduling, call (888) 828-4575. TeleHealth offers treatment that is cutting edge and revolutionary. When it comes to regenerative medicine, bone marrow stem cell injections are excellent because they are outpatient, low risk and showing effective results. Being covered by insurance makes them additionally on the cutting edge at TeleHealth. Stem cell therapy is the latest option for degenerative arthritis of the knees, shoulders, hips, ankles and more. Most treatments for arthritis until now have included excellent pain relief methods such as cortisone. However, the treatment has not altered the course of the disease, but simply acted as a "band aid" for pain relief. The bone marrow derived stem cell treatment has the potential to repair and regenerate arthritic joints. Along with bone marrow derived injections, TeleHealth also offers fat derived stem cell injections along with platelet rich plasma … Continue reading →

RICHMOND When most people think of stem-cell therapy, they think of cutting-edge medicine human medicine, that is. What many dont realize is that the technology can be, and is, applied to our four-legged friends as well. Jim Martin, DVM, a veterinarian who owns and operates four area animal care facilities, including the Waco Animal Hospital, has been using stem-cell therapy to help dogs, mainly with mobility problems, such as arthritis, joint pain and tendon and ligament damage. The therapy can provide canine patients with renewed energy and freedom of movement. Martin, associates, and staff members, have been using the procedure on dogs for about a year, with considerable success. In Kentucky the use of stem-cell therapy has been mainly for horses, Martin explained, but added it works on canines as well. The procedure doesnt come cheap. Martin said the cost ranges from about $1,800 to $2,200. That includes pre-testing to determine if the dog is a good candidate for the procedure, along with surgical anesthetic and other services necessary to complete the procedure. Because the stem cells that are injected come from the animals own body, the risk of rejection or reaction is minimal. The procedures are done in Martins … Continue reading →

Nanomedicine: The Risks and The Potential Scientists are developing the ability to manipulate unbelievably small matter--thousand of times smaller than a human hair. All kinds of magical things can happen at this level...nano technology... By: WOSUColumbus … Continue reading →

BALTIMORE, MD--(Marketwired - Sep 16, 2013) - In a newly released article, Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, notes that there is a buzz in biotech circles regarding the high value of encapsulation technologies and targeted therapy delivery platforms. Firms that have exposure to, or are major participants in these segments are just now beginning to garner significant interest from larger players, thus enabling them to enjoy increasingly favorable valuations. For example, Bind Therapeutics, Inc., a high profile biotech that recently filed to go public via an Initial Public Offering through leading health care investment banks, is one of these companies. Considering the striking similarities between Bind and Nuvilex, Inc. (OTCQB: NVLX), Nuvilex's shares could enjoy a big boost once Bind's IPO registration becomes effective. Bind is developing a therapy using what it terms Accurins. Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy … Continue reading →

BROWNSVILLE Federal authorities say a man who posed as a doctor was part of a scheme that used stem cells from the umbilical cords of women at a border maternity clinic to prey on the hopes of patients with incurable diseases. A 19-page indictment unsealed this week accuses Francisco Dr. Frank Morales, 52, of Brownsville and co-defendants including the owner of a maternity clinic in Del Rio and a researcher in South Carolina of netting at least $1.5 million from procedures Morales performed in Mexico on patients he met in the United States. Birth mothers at the Maternity Care Clinic were told their umbilical cords were being donated to a research facility. Instead, they were sent to the researcher to extract stem cells that were sold to Global Laboratories, LLC, in Scottsdale, Ariz., which then sold them to Morales for his unauthorized procedures, the indictment alleges. Customs and Border Protection officers arrested Morales Dec. 22 in Brownsville. He is to be arraigned in Houston, where the case is pending. Court records show he waived his right to a court-appointed attorney. Clinic owner and licensed midwife Alberto Ramon, 48, of Del Rio, and researcher Vincent Dammai, 40, of Mount Pleasant, S.C., … Continue reading →